Volume 16, Issue 4, pp. 662-670
- Received August 5, 2016.
- Revision received December 1, 2016.
- Accepted December 15, 2016.
- Published first January 30, 2017.
Copyright & Usage
©2017 American Association for Cancer Research.
View Full Text
- Bingbing Dai1,
- David Roife1,
- Ya'an Kang1,
- Joy Gumin2,
- Mayrim V. Rios Perez1,
- Xinqun Li1,
- Michael Pratt1,
- Rolf A. Brekken3,
- Juan Fueyo-Margareto4,
- Frederick F. Lang2, and
- Jason B. Fleming1,*
- 1Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- 2Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- 3Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, Texas.
- 4Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- ↵*Corresponding Author:
Jason B. Fleming, Department of Surgical Oncology, Unit 0107, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030. Phone: 713-745-0890; Fax: 713-745-1921; E-mail: